Servier posted on LinkedIn:
“Yesterday, we had the pleasure of hosting representatives from the Paris Saclay Cancer Cluster (PSCC) at our R&D Institute in Paris-Saclay.
This event reaffirmed our commitment to fostering open collaborations among all players in oncology innovation, including pharmaceutical companies, startups, and academic institutions.
The discussions highlighted the progress made over two years of partnership, focusing on groundbreaking topics such as digital twins and foundation models in cancer research.
Read the insightful interview with Alice de Queylard, Chief Innovation Officer at the Paris Saclay Cancer Cluster (PSCC), and Nathalie de Préville, Director of Public-Private Partnerships at Servier, to learn more about this partnership.”
Other articles from Servier on OncoDaily.
